Home › Funds › Ninepoint Partners LP › GH
Ninepoint Partners LP position in GH
GUARDANT HEALTH INC · Health Care
Ninepoint Partners LP reported holding 19,018 shares of GH (GUARDANT HEALTH INC) in its Q2 2026 13F filing — a position valued at US$2.9M, representing 0.25% of its reported portfolio and ranking #50 among its reported holdings. Ninepoint Partners LP has disclosed GH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Ninepoint Partners LP's GH position evolved
Ninepoint Partners LP first disclosed a stake in GH in Q1 2026 at 12,994 shares (US$1.2M). The position peaked in Q2 2026 at 19,018 shares, worth US$2.9M. Across 2 filings, Ninepoint Partners LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 19,018 shares valued at US$2.9M — an increase of 6,024 shares quarter over quarter.. Notable position changes include a 46% increase in Q2 2026 (shares rose 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 12.99K | $1.20M | New |
| Q2 2026 | 19.02K | $2.85M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GH and 13F data
GH (GUARDANT HEALTH INC) is a Health Care company. 58 other funds we track also report a position in GH — the largest reported positions include Deep Track Capital, LP (US$509.1M), FULLER & THALER ASSET MANAGEMENT, INC. (US$394.4M), EVENTIDE ASSET MANAGEMENT, LLC (US$293.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GH
- Deep Track Capital, LP 3.39M sh · $509.10M · Q2 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 2.63M sh · $394.43M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.96M sh · $293.79M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.62M sh · $243.72M · Q2 2026
- TWO SIGMA ADVISERS, LP 2.38M sh · $243.33M · Q4 2025
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.53M sh · $230.14M · Q2 2026
- RTW INVESTMENTS, LP 1.48M sh · $222.20M · Q2 2026
- Hood River Capital Management LLC 1.40M sh · $209.34M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.31M sh · $196.74M · Q2 2026
- Temasek Holdings (Private) Ltd 1.02M sh · $153.62M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 967.70K sh · $145.18M · Q2 2026
- CADIAN CAPITAL MANAGEMENT, LP 757.39K sh · $113.63M · Q2 2026
More on Ninepoint Partners LP
FAQ
How long has Ninepoint Partners LP held GH?
Ninepoint Partners LP has disclosed GH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Ninepoint Partners LP's current position in GH?
As of Q2 2026, Ninepoint Partners LP holds 19.02K shares of GH (GUARDANT HEALTH INC), valued at $2.85M, representing 0.25% of its reported portfolio and ranking #50.
Has Ninepoint Partners LP been buying or selling GH?
In the latest 13F filing (Q2 2026), Ninepoint Partners LP increased its position in GH. The position peaked in Q2 2026 at 19.02K shares.
Which other funds hold GH?
Other major institutional holders of GH include Deep Track Capital, LP, FULLER & THALER ASSET MANAGEMENT, INC., EVENTIDE ASSET MANAGEMENT, LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.